Ardena Group launches Life Science Ingredients arm

1 Aug 2019

The news business will manufacture chemical ingredients that can be used in the development of drug products, and in the healthcare and cosmetics industries.

CDMO Ardena has launched Ardena LSI, a new arm of its business dedicated to the sale of chemical ingredients and intermediates for the life science industry.

Ardena Group launches Life Science Ingredients arm

Ardena LSI will manufacture chemical ingredients for the development of drug products in the Group’s European GMP certified plants, including BDDE 98% GMP (1,4-Butanediol diglycidyl ether) and EDC-HCl Ultra Pure.

The ingredients can be used by pharmaceutical manufacturers in the development of drug products, and for application in healthcare and cosmetics products such as dermal fillers

Harry Christiaens, CEO of Ardena, said: “The healthcare and cosmetic industry require a high and consistent quality of chemical ingredients to enable the manufacture of safe and reliable products.

“We have built up extensive experience as a CDMO in the area of chemical synthesis and through Ardena LSI we are now harnessing that experience to manufacture high-quality chemical ingredients that are essential for pharmaceutical manufacturers in European markets.

“Customers need suppliers that truly understand the chemistry behind drug development, and we will work closely with them to understand their specific requirements and provide the ingredient quality and volumes that they need according to GMP guidelines.”

Read More

Related news

Funding to accelerate delivery of Univercells' vaccine portfolio

Funding to accelerate delivery of Univercells' vaccine portfolio

11 Oct 2019

European financing to support Univercells’ R&D investments to develop four essential and undersupplied global health vaccines to be produced at affordable prices, high quality and large volumes.

Read more 
Industrial-scale manufacture of therapeutic exosomes

Industrial-scale manufacture of therapeutic exosomes

10 Oct 2019

Coordinated purification process development service accelerates progress to clinical trials, and scale-up manufacturing.

Read more 
Janssen opens new biomanufacturing building in Ireland

Janssen opens new biomanufacturing building in Ireland

8 Oct 2019

Expansion creates 200 new full-time jobs and increases the company’s production capacity by an additional 19,100 m2.

Read more 
BASF and Biomillenia join forces in microbiome research to promote healthy skin

BASF and Biomillenia join forces in microbiome research to promote healthy skin

7 Oct 2019

Research aims to identify novel dermocosmetic active ingredients via unique microbiome-on-a-chip technology.

Read more 
Allergan expands Refresh eye treatment portfolio

Allergan expands Refresh eye treatment portfolio

7 Oct 2019

A trifecta of relief formulated with HydroCell technology offers new artificial tear options for patients suffering from eye dryness.

Read more 
BASF strengthens biotechnology footprint to enter natural F&F ingredients market

BASF strengthens biotechnology footprint to enter natural F&F ingredients market

3 Oct 2019

Market entrance with biotech-based natural vanillin, valencene and nootkatone.

Read more 
Unidose device approved for Tosymra sumatriptan spray

Unidose device approved for Tosymra sumatriptan spray

3 Oct 2019

Provides migraine sufferers with a convenient, patient-friendly delivery approach.

Read more 
One-stop-platform for plant-based nutraceuticals

One-stop-platform for plant-based nutraceuticals

2 Oct 2019

In 2020, nutra brands will look to ensure they have plant-based options across all product classes with many actively looking to move entire portfolios plant-based.

Read more 
BASF's new bioactive ingredient the wellness elixir for healthy skin

BASF's new bioactive ingredient the wellness elixir for healthy skin

1 Oct 2019

The active ingredient is a 100% natural extract from the chaga mushroom, obtained using an innovative eco-friendly technology: subcritical water extraction.

Read more 
Arctoris secures funding to advance novel robotic drug discovery platform

Arctoris secures funding to advance novel robotic drug discovery platform

1 Oct 2019

Platform will enable scientists and biotechnology entrepreneurs worldwide to make discoveries faster and more efficiently,

Read more